Traumatic Injury Clinical Trial Evaluating Tranexamic Acid in Children: A Pilot and Feasibility Study

Completed · Phase 2 · Has a placebo group

Conditions studied: Brain Injuries, Wounds and Injuries, Hemorrhage

In brief

Trauma is the leading cause of death and disability in children in the United States. The long-term goal of this project is to evaluate the benefits and harms of tranexamic acid (TXA; a drug that stops bleeding) in severely injured children. This is a 40-patient pilot study to evaluate the feasibility of two subsequent large-scale studies of TXA in injured children.

Key facts

Study ID
NCT02840097
Run by
Daniel Nishijima, MD, MAS
People needed
31
Starts
2019-03-04
Expected to finish
2020-10-03
Last updated by the study team
2021-09-05

Who can join

Age: any, up to 17. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.